Lawrence Armstrong

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Nicholas A. Kennedy, Graham Heap, Harry Green et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 677 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

Aleksejs Sazonovs, Nicholas A. Kennedy, Loukas Moutsianas et al. · Gastroenterology · 2019 · 409 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial

Nathan J. Brendish, Ahalya Malachira, Lawrence Armstrong et al. · The Lancet Respiratory Medicine · 2017 · 320 citations · Full text

Pharmacy, Infectious Diseases, Antimicrobial Stewardship +16

Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study

Neil Chanchlani, Simeng Lin, Claire Bewshea et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 123 citations · Full text

Medicine, Clinical Sciences, Immunology +17

The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re‐introduction

Michael Logan, Clare Clark, Umer Zeeshan Ijaz et al. · Alimentary Pharmacology & Therapeutics · 2019 · 79 citations · Full text

Medicine, Nutritional Sciences, Pediatrics +16